The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis: What do we know regarding its pharmacokinetics?

Nelson Leung, Thomas E. Witzig

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis: What do we know regarding its pharmacokinetics?'. Together they form a unique fingerprint.